Product Description
Overall, the global extracorporeal membrane oxygenation market was valued at $96 million in 2023. This is expected to increase over the forecast period at a CAGR of 8.3% to reach $167 million.
The full report suite on the global market for extracorporeal membrane oxygenation (ECMO) includes disposable kits and ECMO machines. Getinge, Medtronic, and LivaNova were the top three market share leaders in the global ECMO market.
MARKET DATA INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2030, and Historical Data to 2020
- Recent Mergers & Acquisitions
- Disease Overviews
- Company Profiles, Product Portfolios, and SWOT for Top Competitors
GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MARKET INSIGHTS
The ECMO market is grappling with intense global competition and a fragmented landscape where regional companies hold considerable market shares. This environment fosters competitive pricing, which could dampen overall market growth during the forecast period. Conversely, the rising prevalence of coronary heart disease globally is enlarging the pool of potential ECMO patients. This increase in the patient base is expected to drive the expansion of ECMO procedures performed throughout the forecast period.
GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MARKET SHARE INSIGHTS
In 2023, Getinge led the global ECMO market, providing both disposables and machines with a widespread international presence. As access to ECMO increases, Getinge is poised to capture additional market shares.
Medtronic followed as the second-leading entity in the ECMO space. Its offerings include the Affinity® and Minimax® oxygenation systems within its capital equipment line, alongside disposables. This diverse product range positions Medtronic to broaden its market footprint in the forthcoming years.
LivaNova ranked third in the ECMO market, supplying both machines and disposables. Its notable products include the EOS ECMO® oxygenator, designed for extended procedures, and its perfusion tubing systems, enhancing its portfolio of disposable items.
MARKET SEGMENTATION SUMMARY
- ECMO Disposables
- ECMO Machines
RESEARCH SCOPE SUMMARY
| Report Attribute | Details |
|---|---|
| Regions | North America(Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe(Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East(Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Mongolia, Malaysia, Myanmar, New Zealand, Philippines, Pakistan, Singapore, South Korea, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2023 |
| Forecast | 2024-2030 |
| Historical Data | 2020-2023 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
